Enrollment you can forecast. A network you can hold accountable.
One conversation with Business Development gets you site-level feasibility, with real patient counts, in about a day. 30+ integrated sites, one master contract, live enrollment visibility.
Everything a sponsor needs from a site network, under one operational roof.
DM runs studies the way sponsors need them run: patient access at scale, therapeutic breadth, regulatory rigor, and enrollment you can actually forecast.
Patient Access At Scale
A 1.97M+ proprietary patient database and 130 patient enrollment specialists, with protocol-level patient matching and EMR-enabled identification where applicable.
Therapeutic Index
32 therapeutic areas across Phase I–IV, metabolic, cardiovascular, vaccines, CNS, respiratory, women's health, and more.
Regulatory Rigor
HIPAA, 21 CFR Part 11, and the quality systems enterprise sponsors expect.
Forecastable Enrollment
Real-time pipeline and randomization visibility, enrollment performance you can hold us to, week over week.
One Integrated Site Partner
A single master contract and one point of contact across all 30+ sites, same SOPs, same quality system, everywhere.
Accelerated Startup
Feasibility in 24 hours, contracts in 24 hours, site launch in 27 days, compressed by a pre-screened database and automation.
From protocol to first patient, measured in days, not months.
Every stage of study startup is centralized and instrumented, so the fattest delays in the industry timeline simply aren't yours.
Feasibility · 24 hours
Site-level responses backed by real patient-database counts, not optimistic estimates.
Contracts · 24 hours
Centralized budgets and contracting, averaging 24-hour contract turnaround.
Site activation
Standardized regulatory and IRB workflows across the network, run in parallel.
Site launch · 27 days
From greenlight to activation in 27 days, with first patients enrolled within 24 hours of greenlight.
The only enrollment number that matters is the one you can predict.
DM pairs a proprietary patient database with live forecasting, so you see randomization trajectory by site, and we course-correct before a study slips.
Achieve-Or-Exceed Targets
Across 10,000+ completed trials since 2006, DM's patient-access edge consistently meets or beats enrollment commitments.
Live Randomization Visibility
Per-site randomization and pipeline tracking, sponsors see the same forecast we do, in real time.
50% Diverse Enrollment
Community-rooted, bilingual recruitment built over two decades in the neighborhoods our sites serve.
Quality isn't luck. It's the system.
A single quality management system runs across every site, the reason a sponsor's audit experience is the same in Houston as it is in Brooklyn.
A Clean Regulatory Record
A clean inspection record across the entire network, the clearest proxy for operational discipline.
HIPAA + 21 CFR Part 11
PHI stays protected; electronic records and signatures meet federal requirements end to end.
Unified SOPs
One quality system, one set of SOPs, consistent conduct and data integrity across all 30+ sites.
Audit-Ready Always
Centralized regulatory and document control means inspection readiness is the default state, not a scramble.
Deep expertise across 32 therapeutic areas.
From metabolic and cardiovascular to vaccines and women's health, depth your feasibility team can shortlist with confidence.
Why sponsors consolidate with DM.
DM pairs the reach of a national network with the accountability of a single operating model, privately owned and built for the long term.
| What sponsors need | DM Clinical | Investor-backed networks | Independent sites |
|---|---|---|---|
| One master contract, many sites | 30+ sites, one contract | Varies by entity | One site at a time |
| Patient database at scale | 1.97M+ proprietary | Fragmented | Local only |
| Bilingual / diverse access | 50% diverse, 130 specialists | Limited | Rare |
| Ownership model | Since 2006 | Investor-backed | Often |
| Live enrollment forecasting | Per-site, real time | Inconsistent | Manual |
| Clean inspection record | Clean record | Mixed | Variable |
Five steps from first call to first patient.
Intro call with BD
Tell us the indication, phase, geography, and timeline. We map it to our sites the same day.
Feasibility in ~24 hours
Real patient counts by site and indication, not estimates.
One master contract
Centralized budget and contracting across every selected site, ~24-hour contract turnaround.
Parallel activation
Regulatory, IRB, and site initiation run network-wide, in parallel.
Enroll with live visibility
First patient ~27 days to site launch, then forecast-tracked randomization to the finish.
Sponsor & CRO FAQ.
How fast can DM Clinical provide feasibility?
What is DM Clinical's enrollment track record?
Does DM support Phase I studies?
How does contracting work across multiple sites?
How do we start?
Let's scope your next study.
Send us the indication, phase, and geography. You'll have site-level feasibility, with real patient counts, in about a day.
Contact Business Development